SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

CleanSpark, Inc. is a bitcoin mining technology company, which engages in the management of data centers. Its operations include College Park, Norcross, Washington, Sandersville, Dalton, and Massena. The company was founded by S. Matthew Schultz and Bryan Huber on October 15, 1987 and is headquartered in Henderson, NV.

Cleanspark Inc

CleanSpark is drawing attention for a steep selloff alongside other Bitcoin miners, with traders noting that its shares have fallen sharply even as Bitcoin has held up better. The debate pits bearish concerns about sector pressure, debt costs and heavy short interest against dip-buyers who see value in the companys Meta data-center lease and Bitcoin holdings.

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

CVS Health Corp

CVS is drawing attention as traders position around its upcoming earnings report, with bullish options activity and talk of a technical recovery balanced by concern that weaker Aetna Medicare Advantage star ratings could pressure future bonus revenue. The community is divided between expecting continued momentum and watching for renewed selling.

Ethereum is a global, open-source platform for decentralized applications. In other words, it is a decentralized blockchain platform that enables developers to build and deploy smart contracts and applications without central authority control. Unlike Bitcoin, which primarily functions as digital currency, Ethereum operates as a programmable global computer where developers can create any type of decentralized service.   The platform hosts over $14 billion in DeFi applications with hundreds of thousands of active users across financial protocols, NFT marketplaces, and gaming platforms. Its transition to Proof of Stake in September 2022 reduced energy consumption by over 99%, addressing environmental concerns while strengthening network security.  The network operates through thousands of independent validator nodes that process transactions and execute smart contracts on the Ethereum Virtual Machine. Smart contracts are self-executing programs written in Solidity that automatically carry out agreements when conditions are met, eliminating intermediaries like banks or brokers.   Validators stake ETH as collateral to propose and validate blocks, earning rewards for honest participation while facing penalties for malicious behavior. The EIP-1559 upgrade introduced a dynamic base fee mechanism that burns ETH with each transaction, creating deflationary pressure during high network activity when more ETH is burned than issued to validators.  Vitalik Buterin proposed Ethereum in 2013, but seven co-founders helped build it, including Gavin Wood who created Solidity and the EVM technical specification, and Joseph Lubin who founded ConsenSys. The project launched in July 2015 after raising over $18 million through crowdfunding, quickly becoming the largest blockchain developer community. Major milestones include the 2020 Beacon Chain launch, the 2021 London hard fork implementing fee burning, and the 2022 Merge to Proof of Stake.   Ether (ETH) serves multiple functions: paying transaction fees (gas), staking to secure the network and earn 3-5% annual yields, serving as collateral in DeFi protocols, and purchasing NFTs and digital assets. The asset is increasingly adopted by traditional institutions, with publicly traded companies adding ETH to corporate treasuries to generate staking yields while maintaining blockchain exposure, and in 2024, the SEC approved spot Ethereum ETFs, allowing traditional investors to gain exposure through conventional brokerage accounts.  Ethereum's roadmap focuses on dramatically increasing transaction capacity to over 100,000 per second, reducing confirmation times, and enhancing decentralization while maintaining security against future threats like quantum computing.

Ethereum

Ethereums pullback and difficulty reclaiming key chart levels dominate discussion, amid broader weakness across crypto. Traders are divided between expecting further declines and buying the dip, while some point to bank adoption and tokenization as longer-term support for ETH.

Whirlpool Corp. engages in the manufacturing and marketing of home appliances. Its products include home laundry appliances, refrigerators and freezers, cooking appliances, home dishwashers, and room air-conditioning equipment, mixers, and portable household appliances. The firm's brands include Whirlpool, KitchenAid, Maytag, Consul, Brastemp, Amana, Bauknecht, JennAir, and Indesit. It operates through the following geographical segments: Major Domestic Appliances (MDA) North America, Major Domestic Appliances (MDA) Latin America, Small Domestic Appliances (SDA) Global, and Others. The company was founded by Emory Upton, Fred Upton, and Louis C. Upton on November 11, 1911 and is headquartered in Benton Harbor, MI.

Whirlpool Corp.

Whirlpools weak quarterly results, sharply reduced outlook and suspension of its common dividend have driven heavy selling, with management citing recession-level appliance demand and the Iran war. Traders are split between bargain hunters expecting a rebound and bears warning that weak demand, debt and management concerns could prolong the decline; many reject the companys macroeconomic explanation.

Select Sector SPDR Trust (The) - State Street Health Care Select Sector SPDR ETF

Health Care Select Sector SPDR Fund

Healthcares strong relative performance and move to record highs have drawn attention, with traders describing a rotation into defensive sectors as technology comes under pressure. Many remain bullish on the sectors rebound, while others caution that the rally may be extended and watch for a pullback.

Select Sector SPDR Trust (The) - State Street Energy Select Sector SPDR ETF

Energy Select Sector SPDR Fund

XLE is drawing attention after rallying to a new high alongside elevated crude prices, as traders focus on Middle East shipping and supply-disruption risks. Many see the energy sectors uptrend continuing, while others warn the move looks extended and remains vulnerable to volatile oil prices and changing geopolitical headlines.

ProShares Trust - ProShares UltraPro QQQ 3x Shares

ProShares UltraPro QQQ

A sharp Nasdaq and technology selloff, which traders link to inflation and rate concerns as well as doubts about AI spending, has intensified attention on TQQQs leveraged moves. Some see room for an oversold bounce and are buying dips or calls, while others view the rebound as potentially temporary and expect more downside.

Stellar is an open-source, decentralized network co-founded in 2014 by Jed McCaleb and Joyce Kim to facilitate the fast and low-cost transfer of value across different currencies and assets globally. Managed by the non-profit Stellar Development Foundation, the project serves as a global infrastructure that connects banks, payment systems, and individuals to expand financial access to underserved populations. Its main value proposition lies in providing a bridge between traditional money and digital networks through the use of Anchors, which are trusted entities that hold deposits and issue credits on the ledger.  The network operates using the Stellar Consensus Protocol and a Federated Byzantine Agreement, where nodes choose trusted sets of other nodes to agree on the state of the ledger. This system ensures high throughput and fast finality, where transactions are considered permanent and irreversible within seconds. Key features include a built-in distributed exchange for trading assets without intermediaries and the Soroban platform for developing smart contracts. Users can also utilize the network for tokenizing real-world assets or accessing decentralized finance services like peer-to-peer lending.  Stellar's native token, XLM, is essential for maintaining network integrity by acting as an intermediary to find efficient exchange paths and preventing spam through small transaction fees and minimum account balance requirements. Unlike many other digital assets, the network has no inflation because the community voted to disable the automatic creation of new tokens. While the project received early funding from the payments company Stripe, it is now sustained by a global community of validators and developers rather than traditional venture capital.

Stellar Lumens

XLM is drawing attention for its continued decline and difficulty holding the 17-cent area, with traders blaming persistent selling and broader crypto-market weakness. Dip buyers point to Stellars tokenization and institutional-adoption prospects, while skeptics argue those developments have yet to translate into meaningful token demand.

uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, Netherlands.

uniQure N.V.

uniQure NV

uniQures four-year AMT-130 data for Huntingtons disease have driven attention: the 48-month cUHDRS result showed a weaker, statistically nonsignificant treatment effect than the stronger three-year data. Traders are divided between concern that the benefit may fade and the view that the FDA filing rests on the three-year results, with some arguing patient dropouts and changes to the external control complicate the longer-term comparison.

Midnight is a privacy-first blockchain that blends public verifiability with confidential data handling. You can use Midnight's selective disclosure and ZK proofs to build apps.

Midnight

Midnights mainnet rollout and payment-partnership announcements are drawing interest, while traders debate whether adoption can offset selling tied to NIGHT redemptions and unlocks. Lingering concern about the Wanchain bridge exploit adds to the volatility and skepticism.

statis crypto Watchlist

Bitcoin

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Did Geron Corporation Insiders Breach their Fiduciary Duties to Shareholders?

Did Geron Corporation Insiders Breach their Fiduciary Duties to Shareholders? Did Geron Corporation Insiders Breach their Fiduciary Duties to Shareholders?PR NewswireNEW YORK, Oct. 13, 2026Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation...

Geron Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Geron Corporation - GERN

Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (KSF), announces that KSF has commenced an investigation into Geron Corporation (Geron or the Company) (NasdaqGS: GERN).Throughout 2024, the Company touted the revenue outlook and...

Can Reblozyl Power Bristol Myers' Top-Line Growth Going Forward?

Reblozyl's strong growth is helping Bristol Myers offset declining legacy drug sales, with new indications offering further upside.

Klotho Protein Emerges as a Potential Powerhouse In the Next Generation of Longevity Medicine

Human clinical development is putting one of aging biology’s most closely watched proteins on the biotechnology radar   New York, NY – September 30, 2026 – Klotho is quickly becoming one of the more interesting names in longevity research. What started largely as a research question around aging and biological decline is now moving closer […]
The post Klotho Protein Emerges as a Potential Powerhouse In the Next Generation of Longevity Medicine appeared first on Financial News Media.

Did Geron Corporation Insiders Breach their Fiduciary Duties to Shareholders? Did Geron Corporation Insiders Breach their Fiduciary Duties to Shareholders?PR NewswireNEW YORK, Sept. 25, 2026 Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or...

Geron Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Geron Corporation - GERN Geron Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Geron Corporation - GERNPR NewswireNEW YORK and NEW ORLEANS, Sept. 25, 2026 NEW...

Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (KSF), announces that KSF has commenced an investigation into Geron Corporation (Geron or the Company) (NasdaqGS: GERN). Throughout 2024, the Company touted the revenue outlook and...

Did Geron Corporation Insiders Breach their Fiduciary Duties to Shareholders? Did Geron Corporation Insiders Breach their Fiduciary Duties to Shareholders? PR Newswire NEW YORK, Sept. 2, 2026 Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or...

Kuehn Law Encourages Investors of Geron Corporation to Contact Law Firm

Kuehn Law Encourages Investors of Geron Corporation to Contact Law Firm Kuehn Law Encourages Investors of Geron Corporation to Contact Law Firm PR Newswire NEW YORK, Sept. 2, 2026 NEW YORK, Sept. 2, 2026 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether...

Swedish PM Calls Spanish Illegal Immigrant Amnesty 'Very Bad Idea'

Swedish PM Calls Spanish Illegal Immigrant Amnesty 'Very Bad Idea'

 Authored by Guy Birchall via The Epoch Times,

Swedish Prime Minister Ulf Kristersson has called the Spanish government's amnesty for illegal immigrants a "very bad idea," warning that it could spark another migrant...

Geron Corp. operates as a biotechnology company. It develops a telomerase inhibitor, Imetelstat, in hematologic myeloid malignancies. The firm develops therapeutic products for oncology. The company was founded by Michael D. West on November 28, 1990 and is headquartered in Foster City, CA.

Geron Corp.

Why Did GERN Stock Tumble 10% Pre-Market Today? 

Equity

Extremely Bullish Sentiment

<ul class="summary-bullets"><li>Geron posted RYTELO net product sales of $48 million in the fourth quarter, and the number of ordering accounts increased to roughly 1,300.</li><li>In December, Geron initiated a workforce reduction affecting about one-third of employees, resulting in $17 million in restructuring charges.</li><li>For 2026, Geron projects RYTELO revenue between $220 million and $240 million.</li></ul>Geron Corp. (GERN) reported fourth-quarter and full-year 2025 results on Wednesday, highlighting rising sales of its blood cancer therapy RYTELO as the company sharpens its focus on expanding adoption in lower-risk myelodysplastic syndromes (LR-MDS).Total revenue reached $48 million in the fourth quarter, with a loss per share (EPS) of $0.05. Both the metrics&nbsp;came&nbsp;in below the analysts’ consensus estimates of $50.88 million and a loss of $0.04, respectively, according to Fiscal AI data.&nbsp;<h2 class="st-heading-2">RYTELO Sales And Demand Climb</h2>However, Geron posted RYTELO net product sales of $48 million for Q4 and $183.6 million for the full year. Demand rose 9% in the fourth quarter compared with the prior quarter, while the number of ordering accounts increased by 150 to roughly 1,300.The company said it is supporting more than 10 investigator-sponsored and real-world studies examining RYTELO’s mechanism, potential combinations, and earlier-line use. Initial findings from those efforts are anticipated in the second half of 2026.Following the update,&nbsp;<a href="https://stocktwits.com/symbol/GERN">Geron's stock</a> traded over 10% lower in Wednesday’s premarket. However, on Stocktwits, retail sentiment around the stock remained in ‘bullish’ territory amid ‘high’ message volume levels.&nbsp;<h2 class="st-heading-2">Expenses And Outlook&nbsp;</h2>Operating costs for 2025 were $254.7 million. Research and development spending declined, reflecting reduced clinical trial activity after the FDA’s RYTELO approval in 2024. Selling, general, and administrative costs increased due to expanded commercial efforts. In December, Geron initiated a workforce reduction affecting about one-third of employees, resulting in $17 million in restructuring charges.For 2026, Geron projects RYTELO revenue of $220 million to $240 million, with operating expenses of $230 million to $240 million.GERN stock declined by over 17% in the last 12 months.&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/rbbn-stock-gains-pre-market-today-what-is-behind-the-rally/cZRyd8HRIGE">RBBN Stock Gains Over 8% Pre-Market Today – What’s Behind The Rally?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

A researcher works in the clinical-stage biopharmaceutical company Xencors new laboratory in Pasadena.

Total revenue reached $48 million for the fourth quarter, with a loss per share of $0.05, with both metrics coming in below street estimates. 

iShares US Healthcare ETF

VanEck Pharmaceutical ETF

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$1.12
Prev Close	$1.13
Open	$1.15
Dividend Yield	0.00%
50-Day Moving Average	$1.34
Beta	1.19
Avg. Volume	11.16M
PE Ratio	-10.71

52-Week High	$2.01
52-Week Low	$1.04
Market Capitalization	$719.57M
EPS (Annual)	-$0.1252
Price to Book	3.29
Revenue Per Employee	$712,717.05

Feed

News

Sentiment

Earnings

Fundamentals

Info

GERN Fundamentals